Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display

Molecular Biotechnology

Volumn 51, Issue 3, 2012, Pages 212-220

  Park, Hye Yeon ^a   Lee, Kyoung Jin ^a   Lee, Su Jae ^a   Yoon, Moon Young ^a  

^a Hanyang University   (South Korea)

Author keywords

Breast cancer; Cancer stem cell marker; CD44 binding peptides; Diagnostics probe; M13 phage display

Indexed keywords

BINDING PEPTIDE; BREAST CANCER; CANCER STEM CELLS; CLINICAL APPLICATION; DETECTION SENSITIVITY; M13 PHAGES; NOVEL DIAGNOSTICS; TUMOR PROGRESSIONS;

CELL ADHESION; CHEMICAL DETECTION; DIAGNOSIS; PEPTIDES; PROBES; STEM CELLS;

DISEASES;

CD44 ANTIBODY; HERMES ANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE; RECOMBINANT ANTIGEN; RECOMBINANT CD44 ANTIGEN; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; EPITOPE; FLUORESCEIN ISOTHIOCYANATE; RECOMBINANT PROTEIN; TUMOR MARKER;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER STEM CELL; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; PEPTIDE LIBRARY; PHAGE DISPLAY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; AMINO ACID SEQUENCE; BACTERIOPHAGE M13; BREAST TUMOR; CHEMISTRY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANTIGENS, CD44; BACTERIOPHAGE M13; BREAST NEOPLASMS; EPITOPES; FEMALE; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASTIC STEM CELLS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84871915432     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-011-9458-7     Document Type: Article

References (30)

1. Keysat, S. B., & Jimeno, A. (2010). More than markers: Biological significance of cancer stem cell-defining molecules. Molecular Cancer Therapeutics, 9, 2450-2457.
2. Wilko, T., & Sleeman, J. P. (2006). Tumor-induced lymphangiogenesis: A target for cancer therapy+ Journal of Biotechnology, 124, 224-241.
3. Mehlen, P., & Puisieux, A. (2006). Metastasis: A question of life or death. Nature Reviews, 6, 449-458.
4. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., et al. (1994). A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature, 367, 645-648.
5. Al-Hajj, M., Wicha, S. M., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of USA, 100, 3983-3988.
6. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63, 5821-5828.
7. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research, 65, 10946-10951.
8. Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., Thomas, S. B., & Farrar, W. L. (2008). CD44(+)CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. British Journal of Cancer, 98, 756-765.
9. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature, 445, 111-115.
10. O'Brien, C. A., Pollet, A., Gallinger, S., & Dick, J. El. (2007). A human colon caner cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110.
11. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., et al. (2007). Identification of pancreatic cancer stem cells. Cancer Research, 67, 1030-1037.
12. Daly, P., Collier, T., & Doyle, S. (2002). PCR-ELISA detection of Escherichia coli in milk. Letters in Applied Microbiology, 34, 222-226.
13. Folli, S., Westermann, P., Braichotte, D., Pelegrin, A., Wagnieres, G., van den Bergh, H., et al. (1994). Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Research, 54, 2643-2649.
14. Neri, D., Carnemolla, B., Nissim, A., Leprini, A., Querze, G., Balza, E., et al. (1997). Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nature Biotechnology, 15, 1271-1275.
15. Goldsmith, S. J. (1997). Receptor imaging: competitive or complementary to antibody imaging+ Seminars in Nuclear Medicine, 27, 85-93.
16. Chen, Y., Huang, K., Li, X., Lin, X., Zhu, Z., & Wu, Y. (2010). Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro. Cancer Immunology, Immunotherapy, 59, 933-942.
17. Ladner, R. C., Sato, A. K., Gorzelang, J., & de Souza, M. (2004). Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discovery Today, 9, 525-529.
18. Yang, L.-M. C., Tam, P. Y., Murray, B. J., Mclntire, T. M., Overstreet, C. M., Weiss, G. A., et al. (2006). Virus electrodes for universal biodetection. Analytical Chemistry, 78, 3265-3270.
19. Arap, W., Pasqualini, R., & Ruoslahti, E. (1998). Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279, 377-380.
20. Smith, G. P. (1985). Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315-1317.
21. Henry, B. L., Steven, H. B., Nancy, S., & James, A. W. (1991). Selecting high-affinity binding proteins by monovalent phage display. Biochemistry, 30, 10832-10838.
22. Pande, J., Szewczyk, M. M., & Grover, A. K. (2010). Phage display: Concept, innovations, applications and future. Biotechnology Advances, 28, 849-858.
23. La, I. J., Karim, M., & Yoon, M. Y. (2008). Structure and functional effect of tryptophan mutants of Nicotiana tabacum acetohydroxyacid synthase. Bulletin of the Korean Chemical Society, 29, 1823-1826.
24. Kim, J., Park, H. Y., Choi, K. J., Joung, H., Han, S. H., Lee, J. S., et al. (2006). Screening of peptide bound to anthrax protective antigen by phage display. Journal of Microbiology and Biotechnology, 16, 1784-1790.
25. Feuer, E. J., Wun, W. M., Boring, C. C., Flanders, D., Timmel, M. J., & Tong, T. (1993). The lifetime risk of developing breast cancer. Journal of the National Cancer Institute, 85, 892-897.
26. So, W. K., Choi, K. C., Chan, C. W., & Chair, S. Y. (2010). Agerelated differences in the quality of life of Chinese women undergoing adjuvant therapy for breast cancer. Research in Gerontological Nursing, 29, 1-8.
27. To, K., Fotovati, A., Reipas, K. M., Law, J. H., Hu, K., Wang, J., et al. (2010). Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Research, 70, 2840-2851.
28. Hibino, S., Shibuya, M., Engbring, J. A., Mochizuki, M., Nomizu, M., & Kleinman, H. K. (2004). Malignancy globular domain that binds to CD44 and inhibits identification. Cancer Research, 64, 4810-4816.
29. Phillips, T. M., McBride, W. H., & Pajonk, F. (2006). The response of CD24-/low/CD44+ breast cancer-initiating cell to radiation. Journal of the National Cancer Institute, 98, 1777-1785.
30. Lagadec, C., Vlash, E., Donna, L. D., Meng, Y., Dekmezian, C., Kim, K., et al. (2010). Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Research, 12, R13.